Continuity in Claims of Exception in Biomedical Technologies.

Detalles Bibliográficos
Publicado en:American Journal of Bioethics Vol. 25; no. 1; pp. 89 - 93
Autores principales: Moses, Jacob D., Rich, Miriam, Terris, Callie, Tumilty, Emma
Formato: commentary Journal Article
Publicado: Taylor & Francis Ltd Jan2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=182209617&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 182209617
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15265161
        FKZ
      jtl: American Journal of Bioethics
      issn: 15265161
      maglogo: N
    pubinfo:
      dt: Jan2025
      vid: 25
      iid: 1
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        182209617
        182209617
        182209617
        10.1080/15265161.2024.2433429
        182209617
      ppf: 89
      ppct: 4
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Continuity in Claims of Exception in Biomedical Technologies.
      aug:
        au:
          Moses, Jacob D.
          Rich, Miriam
          Terris, Callie
          Tumilty, Emma
        affil: The University of Texas Medical Branch at Galveston
      sug:
        subj:
          Billing and Claims
          Genetic Engineering
          Technology, Medical
          Ketamine
          Bioethics
          Government Regulations
          Diffusion of Innovation
      pubtype: Academic Journal
      doctype:
        commentary
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N